Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioSpecifics Technologies, a biopharmaceutical company, has posted total revenues of $1.14m for the fourth quarter ended 31 December 2010, compared to $754,122 for the same period in 2009.
Subscribe to our email newsletter
BioSpecifics Technologies’ operating loss was $323,128 for the fourth quarter of 2010, compared to $729,219 for the same period in 2009.
The company has generated net income of $140,169, compared to net loss of $540,637 for the same period, prior year.
For the full year ended 31 December 2010, the company has reported total revenues of $5.66m, compared to $3.16m for the same period in 2009.
The company’s operating loss was $2.03m, compared to $2.16m for the same period in last year.
Net loss was $1.51m for the full year of 2010, compared to $1.96m for the same period in 2009.